AU2002216847A1 - Epitopes of pai-1 - Google Patents

Epitopes of pai-1

Info

Publication number
AU2002216847A1
AU2002216847A1 AU2002216847A AU1684702A AU2002216847A1 AU 2002216847 A1 AU2002216847 A1 AU 2002216847A1 AU 2002216847 A AU2002216847 A AU 2002216847A AU 1684702 A AU1684702 A AU 1684702A AU 2002216847 A1 AU2002216847 A1 AU 2002216847A1
Authority
AU
Australia
Prior art keywords
pai
epitopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216847A
Inventor
Ann-Pascal Bijnens
Paul Declerck
Ann Gils
Thu Hoa Ngo
Jean-Marie Stassen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KU Leuven Research and Development
Original Assignee
KU Leuven Research and Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000153251 external-priority patent/DE10053251A1/en
Priority claimed from DE2001110235 external-priority patent/DE10110235A1/en
Application filed by KU Leuven Research and Development filed Critical KU Leuven Research and Development
Publication of AU2002216847A1 publication Critical patent/AU2002216847A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8132Plasminogen activator inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU2002216847A 2000-10-26 2001-10-25 Epitopes of pai-1 Abandoned AU2002216847A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10053251.9 2000-10-26
DE2000153251 DE10053251A1 (en) 2000-10-26 2000-10-26 New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases
DE2001110235 DE10110235A1 (en) 2001-03-02 2001-03-02 New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases
DE10110235.6 2001-03-02
PCT/BE2001/000186 WO2002034776A2 (en) 2000-10-26 2001-10-25 Epitopes of pai-1

Publications (1)

Publication Number Publication Date
AU2002216847A1 true AU2002216847A1 (en) 2002-05-06

Family

ID=26007505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216847A Abandoned AU2002216847A1 (en) 2000-10-26 2001-10-25 Epitopes of pai-1

Country Status (2)

Country Link
AU (1) AU2002216847A1 (en)
WO (1) WO2002034776A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2652131A1 (en) 1999-04-09 2000-10-19 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
US7374886B2 (en) 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
WO2005094863A1 (en) * 2004-03-30 2005-10-13 Den Kgl.Veterinær-Og Landbohøjskole Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and decting protease inhibitors
RU2301678C1 (en) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Peptide stimulating regeneration of central nervous system neurons, pharmaceutical composition based on thereof and method for its using
US8507436B2 (en) 2007-07-24 2013-08-13 D-Pharm Ltd. Peptides derived from plasminogen activator inhibitor-1 and uses thereof
ES2770507T3 (en) * 2013-08-13 2020-07-01 Sanofi Sa Antibodies directed against plasminogen activator inhibitor type 1 (PAI-1) and uses thereof
TW201722994A (en) 2013-08-13 2017-07-01 賽諾菲公司 Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and uses thereof
MX2016010852A (en) 2014-02-21 2016-10-26 Astellas Pharma Inc New anti-human pai-1 antibody.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1030679A4 (en) * 1997-10-17 2003-03-05 Univ Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator

Also Published As

Publication number Publication date
WO2002034776A3 (en) 2004-01-08
WO2002034776A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2002254570A1 (en) Epitope sequences
AU2002323381A1 (en) Deodorant composition
AU2001264256A1 (en) Plaster
AU2001260327A1 (en) Chair
AU2002225730A1 (en) Compounds
AU2001233691A1 (en) Antiperspirant compositions
AU2001252679A1 (en) Plaster
AU2001267707A1 (en) Antiperspirant formulations
AU2001293728A1 (en) Cosmetic composition
AU2001285790A1 (en) Antiperspirant compositions
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2002217071A1 (en) Novel use of polyhydroxy compounds
AU2002216847A1 (en) Epitopes of pai-1
AU2002225724A1 (en) Motilide compounds
AU2002218278A1 (en) Water-selective cementing composition
AU2001242342A1 (en) Antiperspirants
AU2001267693A1 (en) Antiperspirant formulations
AU2001275201A1 (en) Acne-treating composition
AU2002217285A1 (en) Compounds
AU2001287852A1 (en) Composition
AU2001252200A1 (en) Chair
AU2002221132A1 (en) Novel antibody
AU2002358649A1 (en) Antiperspirant composition
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001262163A1 (en) Composition